(2015). Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. Arthritis Care Res (Hoboken). http://doi.org/10.1002/acr.22429
. K. Sarsour
First name
K.
Last name
Sarsour
(2017). Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis. Semin Arthritis Rheum. http://doi.org/10.1016/j.semarthrit.2016.11.006
. (2017). Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis. Semin Arthritis Rheum. http://doi.org/10.1016/j.semarthrit.2016.10.001
. (2018). Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK. Rheumatol Ther. http://doi.org/10.1007/s40744-018-0112-8
. (2018). Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). http://doi.org/10.1002/acr.23611
.